First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Recruiting · NCT07216066 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD) | Cognition Disorders, Cognitive Dysfunction, Dyskinesias, Muscle Hypertonia, Muscle Rigidity, Neurologic Manifestations, Neuromuscular Manifestations, Parasomnias, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, mood disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, sleep-wake disorder, synucleinopathy | Recruiting | Phase 1 | 2026-09-21 | NCT07216066 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Human Drug Research | Leiden | Netherlands | 1 |
| Montreal Neurological Institute and Hospital | Montreal | Canada | 10 |
| The Ottawa Hospital - Civic Campus | Ottawa | Canada | 3 |